![Julien Miara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julien Miara
Directeur Général chez VALERIO THERAPEUTICS
Profil
Julien Miara is currently the Chairman & Chief Executive Officer at Valerio Therapeutics SA. He is also an Independent Director at Sensorion SA, a Director at TopoTarget UK Ltd., a Director at Versity SA, and a Principal at Invus SAS (Investment Management) since 2018.
Previously, he served as the President at Onxeo US.
Mr. Miara graduated from École des Hautes Études Commerciales du Nord in 2009.
Dernières actualités sur Julien Miara
Postes actifs de Julien Miara
| Sociétés | Poste | Début |
|---|---|---|
| SENSORION | Directeur/Membre du Conseil | - |
| VALERIO THERAPEUTICS | Directeur Général | 13/11/2024 |
| VERSITY | Directeur/Membre du Conseil | - |
Invus SAS (Investment Management)
 Invus SAS (Investment Management) Investment ManagersFinance Invus SAS (Investment Management) (Invus-IM) is the investment management division of Invus SAS, a private equity firm headquartered in Paris, France. The firm is owned by The Invus Group LLC in the US. Invus-IM makes equity investments in public companies. | Analyst-Equity | 01/01/2010 |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Julien Miara
| Sociétés | Poste | Fin |
|---|---|---|
Onxeo US | President | - |
Formation de Julien Miara
École des Hautes Études Commerciales du Nord | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SENSORION | Health Technology |
| VALERIO THERAPEUTICS | Health Technology |
| VERSITY | Finance |
| Entreprise privées | 3 |
|---|---|
Invus SAS (Investment Management)
Invus SAS (Investment Management) Investment ManagersFinance Invus SAS (Investment Management) (Invus-IM) is the investment management division of Invus SAS, a private equity firm headquartered in Paris, France. The firm is owned by The Invus Group LLC in the US. Invus-IM makes equity investments in public companies. | Finance |
Onxeo US | |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Retail Trade |
